Cresset Asset Management »

Beam Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $251k 15k 17.01
2025-03-31 $362k 19k 19.53
2024-12-31 $681k 28k 24.80
2024-09-30 $934k 38k 24.50
2024-06-30 $1.1M 47k 23.43
2024-03-31 $351k 11k 33.04
2023-12-31 $281k 10k 27.22
2021-12-31 $396k 5.0k 79.61
2021-09-30 $333k 3.8k 87.10
2021-06-30 $492k 3.8k 128.69
2021-03-31 $785k 9.8k 80.07
2020-12-31 $215k 2.6k 81.62